Protocol Page


	Study ID (Protocol Number)
	CV181-147


	STUDY LOCATIONS*
	Alianza Research, Inc. Chicago, IL 60611 Recruiting	Billings Clinical Research Center Billings, MT 59101 Recruiting
	Alzohaili Medical Consultants Dearborn, MI 48124 Recruiting	Boca Raton Clinical Research Associates, Inc. Boca Raton, FL 33432 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
	STUDY OVERVIEW
	To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118) in combination with Metformin in pediatric patients with type 2 diabetes

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.